Log In
Print
BCIQ
Print
Print this Print this
 

intranasal diazepam (NRL-1)

  Manage Alerts
Collapse Summary General Information
Company Neurelis Inc.
DescriptionIntranasal formulation of diazepam
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationEpilepsy
Indication DetailsTreat breakthrough seizures associated with epilepsy
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today